ITRM Iterum Therapeutics Plc

Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally.

$0.22
As of 05/27/2022     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Ireland
Country of incorporation:  
IPO date:  05/25/2018
Outstanding shares:  183,353,418
Average volume:  1,116,194
Market cap:   $42,226,292
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.84
PS ratio:   0.00
Return on equity:   7.93%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy